Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zakaria S Khondker

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cell Cycle (Georgetown, Tex.)|September 10, 2009
Temporal differences in DNA replication during the S phase using single fiber analysis of normal human fibroblasts and glioblastoma T98G cellsRebecca A Frum, Zakaria S Khondker, David G Kaufman
Statistics and Its Interface|February 20, 2014
The Bayesian Covariance LassoZakaria S Khondker, Hongtu Zhu, Haitao Chu, et al.
Pigment Cell & Melanoma Research|March 8, 2011
DNA-methylation profiling distinguishes malignant melanomas from benign neviKathleen Conway, Sharon N Edmiston, Zakaria S Khondker, et al.
Cell Reports. Medicine|December 9, 2020
Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1Asaf Poran, Julian Scherer, Meghan E Bushway, et al.
Cancer Cell|August 26, 2022
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancerMark M Awad, Ramaswamy Govindan, Kristen N Balogh, et al.
Cell|October 16, 2020
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder CancerPatrick A Ott, Siwen Hu-Lieskovan, Bartosz Chmielowski, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cell Cycle (Georgetown, Tex.)|September 10, 2009
Temporal differences in DNA replication during the S phase using single fiber analysis of normal human fibroblasts and glioblastoma T98G cellsRebecca A Frum, Zakaria S Khondker, David G Kaufman
Statistics and Its Interface|February 20, 2014
The Bayesian Covariance LassoZakaria S Khondker, Hongtu Zhu, Haitao Chu, et al.
Pigment Cell & Melanoma Research|March 8, 2011
DNA-methylation profiling distinguishes malignant melanomas from benign neviKathleen Conway, Sharon N Edmiston, Zakaria S Khondker, et al.
Cell Reports. Medicine|December 9, 2020
Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1Asaf Poran, Julian Scherer, Meghan E Bushway, et al.
Cancer Cell|August 26, 2022
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancerMark M Awad, Ramaswamy Govindan, Kristen N Balogh, et al.
Cell|October 16, 2020
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder CancerPatrick A Ott, Siwen Hu-Lieskovan, Bartosz Chmielowski, et al.
Pageof 1